Renate Starr
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 37
- CAR-T cell therapy research 34
- Cancer Immunotherapy and Biomarkers 4
-
- Nanowire Synthesis and Applications 11
- Co-authors
- Christine E. Brown (39 shared papers)Stephen J. Forman (33 shared papers)Brenda Aguilar (24 shared papers)Michael C. Jensen (11 shared papers)Julie R. Ostberg (9 shared papers)Behnam Badie (22 shared papers)Michael E. Barish (16 shared papers)Massimo D’Apuzzo (12 shared papers)
- Journals
- Molecular Therapy (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)PLoS ONE (3 papers)Neuro-Oncology (3 papers)Cancer Research (3 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Renate Starr
45 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 2.5k
- Immunology 1.2k
- Genetics 473
- Biomedical Engineering 991
- Genetics 629
Countries citing papers authored by Renate Starr
This map shows the geographic impact of Renate Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Starr more than expected).
Fields of papers citing papers by Renate Starr
This network shows the impact of papers produced by Renate Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Starr. The network helps show where Renate Starr may publish in the future.
Co-authors
The 25 scholars most cited alongside Renate Starr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma Hit paper breakdown → | 2015 | 592 |
| 2 | IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype Hit paper breakdown → | 2019 | 324 |
| 3 | 2013 | 300 | |
| 4 | 2017 | 226 | |
| 5 | 2012 | 185 | |
| 6 | 2020 | 163 | |
| 7 | 2018 | 162 | |
| 8 | 2014 | 144 | |
| 9 | 2013 | 138 | |
| 10 | 2020 | 121 | |
| 11 | 2007 | 120 | |
| 12 | 2009 | 113 | |
| 13 | 2018 | 105 | |
| 14 | 2021 | 103 | |
| 15 | 2010 | 97 | |
| 16 | 2014 | 62 | |
| 17 | 1981 | 52 | |
| 18 | 2019 | 52 | |
| 19 | 2020 | 31 | |
| 20 | 2022 | 18 |
About Renate Starr
Renate Starr is a scholar working on Oncology, Biomedical Engineering, Immunology, Molecular Biology and Electrical and Electronic Engineering, having authored 45 papers that have together received 3.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (34 papers), Nanowire Synthesis and Applications (11 papers), Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Glioma Diagnosis and Treatment (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.2k citations), Genetics (473 citations), Biomedical Engineering (991 citations) and Genetics (629 citations). Renate Starr has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Christine E. Brown, Stephen J. Forman, Brenda Aguilar, Michael C. Jensen, Julie R. Ostberg, Behnam Badie, Michael E. Barish, Massimo D’Apuzzo, Darya Alizadeh and Xin Yang. Their work appears in journals such as Molecular Therapy, Journal for ImmunoTherapy of Cancer, PLoS ONE, Neuro-Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.